Related Experiment Videos
ras oncogene p21 expression in hepatocellular carcinoma
J Jagirdar1, A Nonomura, J Patil
1Immunopathology Laboratory, Veterans Administration Medical Center, Bronx, NY.
Journal of Experimental Pathology
|January 1, 1989
Summary
Ras p21 protein expression is elevated in human hepatocellular carcinoma (HCC), particularly in well-differentiated tumors. This suggests ras p21 plays a role in HCC development and progression.
Area of Science:
- Oncology
- Molecular Biology
- Hepatology
Background:
- Aberrant proto-oncogene expression is linked to liver cancer development.
- Ras p21 protein is a key product of the ras oncogene.
Purpose of the Study:
- To investigate the expression of ras p21 protein in human hepatocellular carcinoma (HCC).
- To correlate ras p21 expression levels with tumor differentiation and stage.
Main Methods:
- Localization of ras p21 in liver tissues using avidin-biotin peroxidase method and monoclonal antibody.
- Semi-quantitative assessment of p21 expression via serial antibody dilutions.
Main Results:
- Increased ras p21 expression was observed in HCC, especially in fibrolamellar and well-differentiated types.
- Tumor dedifferentiation correlated with decreased p21 expression.
- Liver adjacent to HCC showed enhanced p21 expression compared to liver surrounding metastatic carcinoma.
Conclusions:
- Ras p21 upregulation is associated with human HCC development.
- Ras p21 expression levels may serve as a marker for HCC differentiation and progression.